Latest News
Most Popular on DTE Site
- Pawar's daughter on panel that will examine biotechnology Bill 1
- Monsoon arrives over Andaman Sea
- Gujarat pollution board gets a makeover in efficiency 33
- Chaos in the iron age 4
- Poison in disguise 2
- Auroville’s alternative galaxy 2
- 309,000 infants die on first day
- Stage set for GM crops
- So much to give
- Mirage of a river 2
- Environment ministry wants to restore night traffic through Bandipur tiger reserve 52
- A green facade 44
- Diesel: when bad policy makes for toxic hell 38
- Gujarat pollution board gets a makeover in efficiency 33
- What’s good insulation? 30
- How vulnerable are India's nuclear power plants to disaster 28
- Grand distraction called river interlinking 28
- Eat at your own risk 27
- Green energy takes toll on green cover 26
- Temporary solution, permanent jam 25
On Facebook
chloroquine
Ranbaxy launches new anti-malarial drug
Issue Date: Apr 26, 2012
The Indian drug manufacturing company Ranbaxy Laboratories Limited launched a new anti-malarial drug, Synriam on the occasion of World Malaria Day on April 25.
The drug, a combination of arterolane maleate 150 mg and piperaquine phosphate 750 mg, is now available in the market. An adult suffering from malaria will need only one tablet a day for three days. In case of other malaria medicines two to four tablets are required, twice daily for three or more days. The new drug regime will lead to better compliance, says Ranbaxy.
O
P
E
N
DTE Must Read
How come Andhra is left out of the mining loot story ? It is good for the nation if we learn to keep environmental and...
The UN environment report states that Ganga would disappear by 2030.There would be no need to train engineers or even Ganga...
A report published in the Journal of the Federation of American Societies for Experimental Biology suggests that babies of...